Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus Disease 2019 (COVID-
19): A secondary analysis of the WAPM study on COVID-19

With Covid-19 outbreak in these days in every country, we do try our best to overcome all problems by not just taking care of our patients at the hospital but also save and protect ourselves and our beloved ones from Covid-19. Covid-19 is challenging everything and everyone into different directions. But we have to keep ourselves active and productive even in these hectic days in our daily life. I hope you are doing well with your loved one(s).

Regarding the COVID19 pandemic and pregnancy issues, we decided to make a multinational multicentre collaborative effort and study group on that matter to create a joint database to have a scientific outcome which we could help pregnant women and their families. First part of survey is planned to complete on the 1st of May, the second part on the 15th of August and the third part on 15th of December, 2020. Regarding IRB (Institutional review board) issue, this study is not interventional but observational study and we are not getting any personal information of the patients in the database: But if you needed, we can provide one IRB approval which one center has got it at their center.

WAPM Covid-19 Stduy First Analysis ISUOG Journal 2020

WAPM Covid-19 Study Secondary Analysis JPM Journal 2020

Clinical management of coronavirus disease 2019 (COVID-19) in pregnancy: recommendations of WAPM-World Association of Perinatal Medicine

With Covid-19 outbreak in these days in every country, we do try our best to overcome all problems by not just taking care of our patients at the hospital but also save and protect ourselves and our beloved ones from Covid-19. Covid-19 is challenging everything and everyone into different directions. But we have to keep ourselves active and productive even in these hectic days in our daily life. I hope you are doing well with your loved one(s).

These guidelines follow the mission of the World Association of Perinatal Medicine, which brings together groups and individuals throughout the world with the goal of improving outcomes of maternal, fetal and neonatal (perinatal) patients. Guidelines for auditing, evaluation,
and clinical care in perinatal medicine enable physicians diagnose, treat and follow-up of COVID-19-exposed pregnant women. These guidelines are based on quality
evidence in the peer review literature as well as the experience of perinatal expert throughout the world. Physicians are advised to apply these guidelines to the local realities which they face.We plan to update these guidelines as new evidence become available

Download

Guideline for the use of antenatal corticosteroids for fetal maturation

Women at risk of preterm birth before 34 weeks’ gestation are routinely given a course of antenatal corticosteroids (ACS) because there is good evidence that treatment reduces neonatal death, respiratory distress syndrome (RDS) and intraventricular hemorrhage (IVH)

Download document

Recommendations and Guidelines for Perinatal Medicine

The last publication of the WAPM (in cooperation with other scientific societies), Recommendations and Guidelines for Perinatal Medicine, was presented during the Congress in Florence.

Download document